Detalhe da pesquisa
1.
Cardiac involvement by CMR in different genotypic groups of thalassemia major patients.
Blood Cells Mol Dis
; 77: 1-7, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30878912
2.
MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine.
Br J Haematol
; 183(5): 783-795, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334574
3.
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
Am J Hematol
; 92(12): 1349-1355, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929515
4.
Effect of deferasirox on iron overload in patients with transfusion-dependent haemoglobinopathies.
Blood Cells Mol Dis
; 55(4): 382-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460263
5.
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
Am J Hematol
; 90(11): 1008-12, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26228763
6.
Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.
Br J Haematol
; 186(6): e209-e211, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31344255
7.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992281
8.
Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.
Br J Haematol
; 163(4): 520-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24111905
9.
Neridronate improves bone mineral density and reduces back pain in ß-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.
Br J Haematol
; 158(2): 274-282, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22571408
10.
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Front Med (Lausanne)
; 9: 832154, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372393
11.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599433
12.
Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients.
Magn Reson Med
; 64(1): 211-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20572148
13.
Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
Am J Hematol
; 90(9): E189-90, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26044155
14.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Br J Haematol
; 145(2): 245-54, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19236376
15.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Blood Cells Mol Dis
; 42(3): 247-51, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19233692
16.
Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.
Haematologica
; 99(2): e17-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497563
17.
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
Eur Heart J Cardiovasc Imaging
; 19(3): 299-309, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28200076
18.
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form.
Br J Haematol
; 158(5): 668-72, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22765023
19.
Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in ß-Thalassaemia Major Patients: An Italian Perspective.
Clin Drug Investig
; 37(5): 453-464, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185140
20.
The role of anaemia in oxidative and genotoxic damage in transfused ß-thalassaemic patients.
Hematology
; 22(3): 183-191, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27801288